序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
1 电动苹果酒倒酒器 CN200620132861.6 2006-09-27 CN200988761Y 2007-12-12 蒙特塞林·阿里亚斯·杰瑟斯
一种电动倒酒器包括一独立主体,在其底部装有一管状部件,通过该管状部件使倒酒器对应于瓶颈。在所述管状部件中,有一长条的抽管沿中心向外延伸,从而穿进瓶中并且依靠主体内部的一个酒吸起瓶中液体,即利用推进的方式将苹果酒强有力地射进玻璃杯中。
2 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents US235400 1999-01-22 US6153217A 2000-11-28 Tuo Jin; Leila Zarif; Raphael Mannino
A process for producing a small-sized, lipid-based cochleate is described. Cochleates are derived from liposomes which are suspended in an aqueous two-phase polymer solution, enabling the differential partitioning of polar molecule based-structure by phase separation. The liposome-containing two-phase polymer solution, treated with positively charged molecules such as Ca.sup.2+ or Zn.sup.2+, forms a cochleate precipitate of a particle size less than one micron. The process may be used to produce cochleates containing pharmaceutical agents or biologically relevant molecules. Small-sized cochleates may be administered orally or through the mucosa to obtain an effective method of treatment.
3 Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases US192421 1998-11-16 US5965137A 1999-10-12 Edward J. Petrus
A topical composition for the delivery of bio-affecting agents through the protective outer layer of skin into the underlying tissues and into the general circulation to prevent the causes and symptoms of vector-borne diseases. The transdermal penetration is achieved by the use of an essential volatile oil with insect repellent capabilities, such as eucalyptus oil. The bio-affective agents may be a combination of a zinc salt and form of vitamin A. A zinc salt may also be used for photoprotective purposes. The topical composition can be formulated as a solution, suspension, cream, ointment, gel, film or spray.
4 Herbal composition for stimulating blood circulation US816936 1997-03-14 US5942233A 1999-08-24 Teh Shan Chang
This invention relates to an herb composition which comprises an amount of 30 to 45% by weight of one or more herbs for invigorating of blood circulation, an amount of 55 to 70% by weight of one or more herbs for excreting toxin from human body, and an amount of 0.5 to 4% by weight of one or more substances for keratin malacoma, all of which are based on the total weight of the composition, wherein the herb for invigorating of blood circulation is selected from the group consisting of Prunnus persica, south apricot kernel, white pepper (Piper migrum), glutinous rice (Oryza sativa) and white astragaluis (Common Bletillah Tuber); the herb for excreting toxin from human body is selected from the group consisting of Cassiope stelleriana, west carthamus (Crocus sativus), Lonicera japonica, rhubarb (Rheum officinale), Bezoar bovis, Liquorice powder (Glycyrrhiza uralensis), Salvia multiorrhiza, ligusticum (Cnidium officinale), Momordica cochinchinensis, achyranthes (Achyrathes bidentata) and astragalus (Astragalus hiroshimanus); and the substance for keratin malacoma is selected from the group consisting of vinegar, acetate salt, Szechwan notoginseng and Rehmannia glufinosa. This invention also relates to a paste containing the present herb composition which is produced by mixing the herb composition with vinegar, water or wine and optionally a binder. The paste is useful for reestablishing of vital energy, invigorating of blood circulation and elimination of blood stasis and for cold remedy by applying the paste on the sole of the human's foot.
5 Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds US973593 1998-02-11 US5916566A 1999-06-29 Leslie Z. Benet; Vincent J. Wacher; Reed M. Benet
A method for increasing bioavailabilty of an orally administered hydrophobic pharmaceutical compound, which comprises orally administering the pharmaceutical compound to a mammal in need of treatment with the compound concurrently with an essential oil or essential oil component in an amount sufficient to provide bioavailability of the compound in the presence of the essential oil or essential oil component greater than bioavailability of the compound in the absence of the essential oil or essential oil component, wherein the essential oil or essential oil component has an activity of at least 10% inhibition at a concentration 0.01 wt. % or less in an assay that measures reduced conversion of cyclosporine to hydroxylated products using an assay system containing 250 .mu.g rat liver microsomes, 1 .mu.M cyclosporine, and 1 .mu.M reduced nicotinamide adenine dinucleotide phosphate (NADPH) in 1 ml of 0.1 M sodium phosphate buffer, pH 7.4.
6 Processed ginseng product with enhanced pharmacological effects US660448 1996-06-07 US5776460A 1998-07-07 Nak Doo Kim; Man Ki Park; Seung Ki Lee; Jeong Hill Park; Jong Moon Kim
A processed ginseng product with enhanced pharmacological effects is provided due to a heat-treatment at a high temperature of 120.degree. to 180.degree. C. for 0.5 to 20 hours so as to make a ratio of ginsenoside (Rg.sub.3 +Rg.sub.5) to (Rc+Rd+Rb.sub.1 +Rb.sub.2) above 1.0.
7 Pharmaceutical composition for increasing immunity and decreasing side effects of anticancer chemotherapy US732146 1985-05-09 US4687761A 1987-08-18 Yaguang Liu
A new pharmaceutical composition for treatment and prevention of side effects of anticancer chemotherapy and radiotherapy and increasing the immune function contains Ferulic acid, Ginsenoside, Anethole and sodium Cinnamate. Processes for producing these components and related pharmacological effect are provided.
8 Preparation for deactivating viruses and process for producing same US706470 1985-02-28 US4595593A 1986-06-17 Erich Wolf; Andreas Lembke; Rolf Deininger
The invention relates to a process and a preparation for deactivating viruses inside living human and animal organisms by application of a terpene obtainable from aromatic plants by steam distillation. The terpenes cited are: black pepper oil, cinnamon flower oil, cardamom oil, linallyl acetate, cinnamic aldehyde, safrol, carvon and cis/trans citral.
9 Anti-acne composition US553977 1983-11-21 US4545990A 1985-10-08 Carol Le Foyer de Costil; Liliane Ayache; Jean-Paul Tisseyre
A composition for the local treatment of acne comprises from 1 to 20 weight percent of benzoyl peroxide and at least one other active principle selected from collagenic palmitoyl acid, glycyrrhetinic acid, bisabolol and a meristem extract.
10 Process and preparation for deactivating viruses US184135 1980-09-04 US4402950A 1983-09-06 Erich Wolf; Andreas Lembke; Rolf Deininger
The invention relates to a process and a preparation for deactivating viruses inside living human and animal organisms by application of a terpene obtainable from aromatic plants by steam distillation. The terpenes cited are: black pepper oil, cinnamon flower oil, cardamon oil, linallyl acetate, cinnamic aldehyde, safrol, carvon and cis/trans citral.
11 Therapeutic agent for the external treatment of psoriasis, tinea and eczemas US33154 1979-04-25 US4235889A 1980-11-25 Walter Evers
The subject of the invention is a pharmaceutical composition for the external treatment of psoriasis, tinea and eczemas, comprising coconut oil, palm kernel oil, an extract of Laurus nobilis (Linn.) and an emulsifier.
12 Brough US469850D US469850A 1892-03-01
13 Aaron rosenberg US444398D US444398A 1891-01-06
14 Liniment US416409D US416409A 1889-12-03
15 Eye-salve US392904D US392904A 1888-11-13
16 Composition for cleaning and preserving carpets US392205D US392205A 1888-11-06
17 Ohaeles p US327883D US327883A 1885-10-06
18 Bitters US327603D US327603A 1885-10-06
19 joslin tueneb US260140D US260140A 1882-06-27
20 Bitters US238581D US238581A 1881-03-08
QQ群二维码
意见反馈